104 related articles for article (PubMed ID: 38743700)
1. Cutaneous T-cell pseudolymphoma successfully treated with topical delgocitinib.
Hoshina D; Kimura A
Int J Dermatol; 2024 May; ():. PubMed ID: 38743700
[No Abstract] [Full Text] [Related]
2. Differential NFATc1 Expression in Primary Cutaneous CD4+ Small/Medium-Sized Pleomorphic T-Cell Lymphoma and Other Forms of Cutaneous T-Cell Lymphoma and Pseudolymphoma.
Magro CM; Momtahen S
Am J Dermatopathol; 2017 Feb; 39(2):95-103. PubMed ID: 27097342
[TBL] [Abstract][Full Text] [Related]
3. Pseudolymphoma and cutaneous lymphoma: facts and controversies.
Bergman R
Clin Dermatol; 2010; 28(5):568-74. PubMed ID: 20797521
[TBL] [Abstract][Full Text] [Related]
4. Progression of cutaneous B-cell pseudolymphoma to cutaneous B-cell lymphoma.
Kulow BF; Cualing H; Steele P; VanHorn J; Breneman JC; Mutasim DF; Breneman DL
J Cutan Med Surg; 2002; 6(6):519-28. PubMed ID: 12404039
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous pseudolymphoma due to topical application of 4% hydroquinone cream for melasma.
Dar NR; Shaheen ; Mustafvi SA; Raza N
J Coll Physicians Surg Pak; 2005 Aug; 15(8):496-7. PubMed ID: 16202363
[TBL] [Abstract][Full Text] [Related]
6. Analysis of clonality in cutaneous B-cell lymphoma and B-cell pseudolymphoma using skin flow cytometry: Comparison of immunophenotyping and gene rearrangement studies.
Nakagawa Y; Hamada T; Takahashi T; Miyake T; Hirai Y; Iwatsuki K; Morizane S
J Dermatol; 2022 Feb; 49(2):246-252. PubMed ID: 34263482
[TBL] [Abstract][Full Text] [Related]
7. Treatment of cutaneous pseudolymphoma with hydroxychloroquine.
Stoll DM
J Am Acad Dermatol; 1983 May; 8(5):696-9. PubMed ID: 6863629
[TBL] [Abstract][Full Text] [Related]
8. Analysis of clonality of atypical cutaneous lymphoid infiltrates associated with drug therapy by PCR/DGGE.
Brady SP; Magro CM; Diaz-Cano SJ; Wolfe HJ
Hum Pathol; 1999 Feb; 30(2):130-6. PubMed ID: 10029439
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous Pseudolymphoma.
Mitteldorf C; Kempf W
Surg Pathol Clin; 2017 Jun; 10(2):455-476. PubMed ID: 28477891
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous MALT-lymphoma: from cutaneous immunocytoma and pseudolymphoma to the current (and future) conceptions.
Fernandez-Flores A
Rom J Morphol Embryol; 2013; 54(1):7-12. PubMed ID: 23529303
[TBL] [Abstract][Full Text] [Related]
11. Lymphoma or pseudolymphoma: A report of six cases and review of the literature.
Tian Z; Shiyu Z; Tao W; Li L; Yuehua L; Hongzhong J
Dermatol Ther; 2019 Jul; 32(4):e12807. PubMed ID: 30589489
[TBL] [Abstract][Full Text] [Related]
12. T-cell rich angiomatoid polypoid pseudolymphoma: a novel cutaneous pseudolymphoma.
Sandhya V; Jayaraman A; Srinivas C
Indian J Dermatol; 2014 Jul; 59(4):361-3. PubMed ID: 25071255
[TBL] [Abstract][Full Text] [Related]
13. HIV-related CD8+ cutaneous pseudolymphoma: efficacy of methotrexate.
Ingen-Housz-Oro S; Sbidian E; Ortonne N; Penso-Assathiany D; Chambrin V; Bagot M; Bachelez H; Wolkenstein P; Chosidow O
Dermatology; 2013; 226(1):15-8. PubMed ID: 23343593
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous pseudolymphoma: A clinicopathological study and immunohistochemical patterns.
Sari Aslani F; Sepaskhah M; Safaei A; Jashounia Hormozi S
Caspian J Intern Med; 2021 Apr; 12(3):283-289. PubMed ID: 34221277
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous intravascular CD30+ T-cell pseudolymphoma occurring in a regressing keratoacanthoma.
Kailas A; Elston DM; Crater SE; Cerruto CA
J Cutan Pathol; 2018 Apr; 45(4):296-298. PubMed ID: 29369392
[TBL] [Abstract][Full Text] [Related]
16. A case of cutaneous pseudolymphoma with a distinctive appearance treated successfully by intralesional interferon alpha-1b and corticosteroids.
Zeng SH; Chen SY; Tang XY; Wang L
Dermatol Ther; 2020 May; 33(3):e13410. PubMed ID: 32298538
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous B-cell Pseudolymphoma: A Rare Case Masquerading a Thoracic Mass in a Fourteen-Year-Old Male Patient.
Oikonomidi C; Troupi M; Marinos L; Liatsos D; Chrysikos D; Filippou D; Troupis T
Cureus; 2023 Apr; 15(4):e38003. PubMed ID: 37223157
[TBL] [Abstract][Full Text] [Related]
18. Phenytoin Induced Cutaneous B Cell Pseudolymphoma.
Riyaz N; Sasidharanpillai S; Aravindan KP; Nobin BK; Raghavan NT; Nikhila PK
Indian J Dermatol; 2015; 60(5):522. PubMed ID: 26538730
[TBL] [Abstract][Full Text] [Related]
19. Sodium valproate-induced cutaneous pseudolymphoma followed by recurrence with carbamazepine.
Cogrel O; Beylot-Barry M; Vergier B; Dubus P; Doutre MS; Merlio JP; Beylot C
Br J Dermatol; 2001 Jun; 144(6):1235-8. PubMed ID: 11422049
[TBL] [Abstract][Full Text] [Related]
20. Acral angiokeratoma-like pseudolymphoma in a middle-aged woman.
Geller S; Markova A; Pulitzer M; Myskowski PL
J Cutan Pathol; 2017 Oct; 44(10):878-881. PubMed ID: 28675468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
